You have 9 free searches left this month | for more free features.

rucaparib

Showing 1 - 25 of 40

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Small Cell Lung Cancer, Extra-Pulmonary Small Cell Carcinomas Trial run by the NCI (PLX038, Rucaparib)

Active, not recruiting
  • Small Cell Lung Cancer
  • Extra-Pulmonary Small Cell Carcinomas
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Biliary Tract Cancer Trial in Boston, Ann Arbor, Nashville (Rucaparib, Nivolumab)

Active, not recruiting
  • Biliary Tract Cancer
  • Boston, Massachusetts
  • +2 more
Dec 6, 2022

Prostate Cancer Trial in Salt Lake City (Rucaparib)

Active, not recruiting
  • Prostate Cancer
  • Rucaparib
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Jun 23, 2022

Metastatic Castration-resistant Prostate Cancer Trial in San Francisco, Providence (Rucaparib, Copanlisib)

Active, not recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • San Francisco, California
  • +1 more
Nov 22, 2022

Advanced Solid Tumor Trial in Akashi, Hidaka, Tsukiji (Rucaparib)

Completed
  • Advanced Solid Tumor
  • Rucaparib
  • Akashi, Hyogo, Japan
  • +2 more
May 16, 2022

Rucaparib in Rucaparib Access Program in Spain - A GEICO Study

Completed
  • Epithelial Ovarian Cancer
  • +2 more
  • Rucaparib
  • Almería, Andalucía, Spain
  • +22 more
Sep 22, 2022

Leiomyosarcoma Trial in United States (Rucaparib, Nivolumab)

Active, not recruiting
  • Leiomyosarcoma
  • Basking Ridge, New Jersey
  • +6 more
Sep 6, 2022

Breast Cancer Trial in United States (Rucaparib, Radiotherapy)

Active, not recruiting
  • Breast Cancer
  • Rucaparib
  • Radiotherapy
  • Norwalk, Connecticut
  • +7 more
Aug 31, 2022

Breast Cancer Trial in Tucson (Rucaparib)

Active, not recruiting
  • Breast Cancer
  • Rucaparib
  • Tucson, Arizona
    University of Arizona Cancer Center
Feb 24, 2022

Metastatic Castration Resistant Prostate Cancer Trial in Atlanta, Minneapolis, Nashville (Rucaparib, Enzalutamide, Abiraterone)

Active, not recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • Rucaparib
  • +2 more
  • Atlanta, Georgia
  • +2 more
Jan 24, 2022

Endometrial Cancer, Uterine Carcinosarcoma Trial in New York, Bethlehem, Milwaukee (Rucaparib, Bevacizumab, Atezolizumab)

Active, not recruiting
  • Endometrial Cancer
  • Uterine Carcinosarcoma
  • Rucaparib
  • +2 more
  • New York, New York
  • +2 more
Apr 4, 2022

Pancreatic Cancer Trial in Philadelphia (RUCAPARIB)

Active, not recruiting
  • Pancreatic Cancer
  • RUCAPARIB
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Nov 10, 2021

Esophagus Cancer, Adenocarcinoma, Stomach Cancer, Adenocarcinoma Trial in United States (Rucaparib, Ramucirumab, Nivolumab)

Recruiting
  • Esophagus Cancer, Adenocarcinoma
  • Stomach Cancer, Adenocarcinoma
  • Rucaparib
  • +2 more
  • Chicago, Illinois
  • +7 more
Jan 31, 2022

Stage IV NSCLC Trial in Ann Arbor, Saint Louis, Columbus (Pembrolizumab, Pemetrexed, Carboplatin)

Recruiting
  • Stage IV Non-small Cell Lung Cancer
  • Ann Arbor, Michigan
  • +2 more
Oct 4, 2021

Advanced (Stage IIIB-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer Trial in Italy (Carboplatin, Paclitaxel,

Recruiting
  • Advanced (Stage IIIB-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer
  • Legnago, Italy
  • +6 more
Aug 24, 2021

Metastatic Breast Cancer Trial in Lyon, Marseille (rucaparib)

Completed
  • Metastatic Breast Cancer
  • rucaparib
  • Lyon, France
  • +1 more
Jun 5, 2021

Solid Tumor, Unspecified, Adult Trial in San Francisco (Rucaparib, Irinotecan)

Completed
  • Solid Tumor, Unspecified, Adult
  • San Francisco, California
    University of California San Francisco
Mar 2, 2021

Prostate Cancer, Endometrial Cancer Trial in Chicago (Rucaparib, Nivolumab)

Terminated
  • Prostate Cancer
  • Endometrial Cancer
  • Chicago, Illinois
    University of Chicago Medical Center
Feb 15, 2021

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in United States (Rucaparib, Nivolumab)

Terminated
  • Epithelial Ovarian Cancer
  • +4 more
  • Clovis, California
  • +4 more
May 19, 2021

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Germany (Rucaparib, Placebos)

Recruiting
  • Ovarian Cancer
  • +3 more
  • Rucaparib
  • Placebos
  • Berlin, Germany
  • +22 more
Aug 30, 2021

Metastatic Castration-Resistant Prostate Cancer, Ovarian Cancer, Epithelial Ovarian Cancer Trial in Worldwide (Rucaparib)

Enrolling by invitation
  • Metastatic Castration-Resistant Prostate Cancer
  • +5 more
  • Rucaparib
  • Lakewood, Colorado
  • +37 more
Jan 18, 2022

Mesothelioma, Malignant Trial in Leicester (Rucaparib, Abemaciclib, pembrolizumab & bemcentinib)

Recruiting
  • Mesothelioma, Malignant
  • Rucaparib
  • +4 more
  • Leicester, United Kingdom
    University Hospitals of Leicester NHS Trust
Apr 6, 2022

Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial in Worldwide (Chemotherapy, Rucaparib)

Active, not recruiting
  • Ovarian Cancer
  • +3 more
  • Denver, Colorado
  • +76 more
Feb 20, 2022

Ovarian Cancer Trial in Villejuif (AsiDNA, Niraparib, Olaparib)

Recruiting
  • Ovarian Cancer
  • Villejuif, Val De Marne, France
    Gustave Roussy
Sep 27, 2021

Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Worldwide (Rucaparib)

Completed
  • Ovarian Cancer
  • +3 more
  • Rucaparib
  • San Francisco, California
  • +15 more
Jan 19, 2021